Selective T cell receptor decrease in peripheral blood T lymphocytes of patients with polymyalgia rheumatica and giant cell arteritis

Annals of the Rheumatic Diseases

Volumn 63, Issue 1, 2004, Pages 54-60

  Lopez Hoyos, M ^a   Bartolome Pacheco, M J ^a   Blanco, R ^a   Rodriguez Valverde, V ^a   Martinez Taboada, V M ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; LYMPHOCYTE SURFACE MARKER; T LYMPHOCYTE RECEPTOR;

AGED; ARTICLE; CELL LOSS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GIANT CELL ARTERITIS; HLA TYPING; HUMAN; LABORATORY TEST; MALE; MEMORY CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATIC POLYMYALGIA; STATISTICAL ANALYSIS; T LYMPHOCYTE;

AGED; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; HISTOCOMPATIBILITY TESTING; HLA-DR ANTIGENS; HUMANS; IMMUNOPHENOTYPING; MALE; MIDDLE AGED; POLYMYALGIA RHEUMATICA; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SUPERANTIGENS; T-LYMPHOCYTE SUBSETS; TEMPORAL ARTERITIS;

EID: 0347320525     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2003.005900     Document Type: Article

References (55)

1. Levine SM, Hellmann DB. Giant cell arteritis. Curr Opin Rheumatol 2001;14:3-10.
2. Armona J, Rodriguez Valverde V, Gonzalez-Gay MA, Figueroa M, Fernandez-Sueiro JL, Blanco R, et al. Arteritis de células gigantes. Estudio de 191 pacientes. Med Clin (Barc) 1995;105:734-7.
3. Martínez-Taboada V, Brack A, Hunder GG, Goronzy JJ, Weyand CM. The inflammatory infiltrate in giant cell arteritis selects against B lymphocytes. J Rheumatol 1996;23:1011-14.
4. Rodriguez-Valverde V, Sarabia J, González-Gay MA, Figueroa M, Armona J, Blanco R, et al. Risk factors and predictive models of giant cell arteritis in polymyalgia rheumatica. Am J Med 1997;102:331-6.
5. Martinez-Taboada VM, Goronzy JJ, Weyand CM. Conceptos actuales sobre la patogenia de la arteritis de células gigantes. Rev Esp Reumatol 1994;21:293-9.
6. Weyand CM, Martínez-Taboada V, Goronzy JJ. Current ideas on the role of HLA molecules in human diseases. Clinical Immunology Newsletter 1996;16:14-21.
7. Weyand CM, Hunder NN, Hicok KC, Hunder GG, Goronzy JJ. Comparison of polymyalgia rheumatica, giant cell arteritis, and rheumatoid arthritis by genetic linkage analysis. Arthritis Rheum 1994;37:514-20.
8. Martinez-Taboada V, Hunder NN, Hunder GG, Weyand CM, Goronzy JJ. Recognition of tissue residing antigen by T cells in vasculitic lesions of giant cell arteritis. J Mol Med 1996;74:695-703.
9. Simpson IJ, Skinner MA, Geursen A, Peake JS, Abbott WG, Frase JD, et al. Peripheral blood lymphocytes in systemic vasculitis: increased T cell receptor Vb2 gene usage in microscopic polyarteritis. Clin Exp Immunol 1995;101:220-6.
10. Rodriguez-Valverde V, Martinez-Taboada VM, Gonzalez-Gay MA. Vasculitis: Concepto, etiopatogenia y clasificacion. Rev Esp Reumatol 1993;20:355-60.
11. Weyand CM, Goronzy JJ. Giant cell arteritis as an antigen driven disease. Rheum Dis Clin North Am 1995;21:1027-39.
12. Weyand CM, Schonberger J, Oppitz U, Hunder NNH, Hicok KC, Goronzy JJ. Vascular lesions in giant cell arteritis share clonally expanded T cell specificities. J Exp Med 1994;179:951-60.
13. Brack A, Geisler A, Martínez-Taboada V, Younge BR, Goronzy JJ, Weyand CM. Giant cell vasculitis is a T cell-dependent disease Mol Med 1997;8:530-43.
14. Pawelec G, Solana R. Immunosenescence. Immunol Today 1997;18:514-16.
15. Castle SC. Clinical relevance of age-related immune dysfunction Clin Infect Dis 2000;31:578-85.
16. Ginaldi L, De Martinis M, Dostilio A, Marini L, Loreto F, Modesti M, et al. Changes in the expression of surface receptors on lymphocyte subsets in the elderly: quantitative flow cytometric analysis. Am J Hematol 2001;67:63-72.
17. Malinowki K, Rapaport FT. Effects of aging upon the expression of differentiation and class II MHC on the surface of T lymphocytes from normal human subjects. Cell Immunol 1995;162:68-73.
18. Chuang T-Y, Hunder GG, Ilstrup DM, Kurland LT. Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. Ann Intern Med 1982;97:672-80.
19. Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthrirtis Rheum 1990;33:1122-8.
20. Martínez-Taboada V, Blanco R, Fito C, Bartolome Pacheco MJ, Rodríguez-Valverde V. Circulating CD8+ T cells in polymyalgia rheumatica and giant cell arteritis: a review. Semin Arthritis Rheum 2001;30:257-71.
21. Vitetta ES, Berton MT, Burger C, Kepron M, Lee WT, Yin XM. Memory B and T cells. Ann Rev Immunol 1991;9:487-98.
22. Martinez-Taboada VM, Goronzy JJ, Weyand CM. Clonally expanded CD8 T cells in patients with polymyalgia rheumatica and giant cell arteritis. Clin Immunol Immunopathol 1996;79:263-70.
23. Grunewald J, Andersson R, Rydberg L, Gigliotti D, Schaufelberger C, Hansson GK, et al. CD4+ and CD8+ T cell expansions using selected TCR V and J gene segments at the onset of giant cell arteritis. Arthritis Rheum 1994;37:1221-7.
24. Martínez-Taboada V, Hunder GG, Weyand CM, Goronzy JJ. Steroid responsiveness of clonal CD8 populations in giant cell arteritis and polymyalgia rheumatica [abstract]. Arthritis Rheum 1995;38(suppl):S189.
25. Acha-Orbea H. Bacterial and viral superantigens: roles in autoimmunity? Ann Rheum Dis 1993;52:S6-16.
26. Irwin MJ, Gascoigne RJ. Interplay between superantigens and the immune system. J Leukoc Biol 1993;54:495-503.
27. Gonzalez-Gay MA, Rodriguez-Valverde V, Blanco R, Fernandez-Sueiro JL, Armona J, Figueroa M, et al. Polymyalgia rheumatica without significantly increased ESR: a more benign syndrome. Arch Intern Med 1997;157:317-20.
28. González-Gay MA, Blanco R, Rodríguez-Valverde V, Martínez-Taboada VM, Delgado M, Figueroa M, et al. Permanent visual loss and cerebrovascular accidents in giant cell arteritis. Predictors and response to treatment. Arthritis Rheum 1998;41:1497-504.
29. Martínez-Tabooda VM, Bartolome-Pacheco MJ, Lopez-Hoyos M, Blanco R, Mata C, Rodríguez-Valverde V. T lymphocytes in polymyalgia rheumatica and giant cell arteritis: T cell receptor usage and phenotype analysis [abstract]. Arthritis Rheum 1999;42(suppl):S209.
30. Martinez-Taboada VM, Bartolome-Pacheco MJ, Amado JA, Blanco R, Garcia-Unzueta MT, Rodriguez-Valverde V, et al. Changes in peripheral blood lymphocyte subsets in elderly subjects are associated with an impaired function of the hypothalamic-pituitary-adrenal axis. Mech Ageing Dev 2002;123:1477-86.
31. Effros RB. Loss of CD28 expression on lymphocytes: a marker of replicative senescence. Dev Comp Immunol 1997;21:471-8.
32. Posnett DN, Sinha R, Kabak S, Russo C. Clonal populations of T cells in normal elderly humans: the equivalent to "benign monoclonal gammapathy". J Exp Med 1994;179:609-18.
33. Monteiro J, Hingorani R, Choi I-H, Silver J, Pergolizzi R, Gregersen PK. Oligoclonality in the human CD8+ T cell repertoire in normal subjects and monozygotic twins: implications for studies of infectious and autoimmune diseases. Mol Med 1995;1:614-24.
34. Schwab R, Szabo P, Manavalan JS, Weksler ME, Posnett DN, Pannetier C, et al. Expanded CD4+ and CD8+ cell clones in elderly humans. J Immunol 1997;158:4493-9.
35. Weyand CM, Goronzy JJ. Multisystem interactions in the pathogenesis of vasculitis. Curr Opinion Rheumatol 1997;9:3-11.
36. Nityanand S, Giscombe R, Srivastava S, Hjelmström P, Sanjjevi CB, Sinha N, et al. A bias in the alphabeta T cell receptor gene usage in Takayasu's arteritis. Clin Exp Immunol 1997;107:261-8.
37. Esin S, Gül A, Hodara V, Jeddi-Tehrani M, Dilsen N, Koniçe M, et al. Peripheral blood T cell expansions in patients with Behçets disease. Clin Exp Immunol 1997;107:520-7.
38. Abe J, Kotzin BL, Jujo K, Melish ME, Glode MP, Kohsaka T, et al. Selective expansion of T cells expressing T-cell receptor variable regions V beta 2 and V beta 8 in Kawasakis disease. Proc Natl Acad Sci USA 1992;89:4066-70.
39. Paliard X, West SG, Lafferty JA, Clements JR, Kappler JW, Marrack P, et al. Evidence for the effects of a superantigen in rheumatoid arthritis. Science 1991;253:325-9.
40. Navaneetham D, Penn AS, Howard JF Jr, Conti-Fine BM. TCR-Vbeta usage in the thymus and blood of myasthenia gravis patients. J Autoimmun 1998;11:621-33.
41. Dalwadi H, Wei B, Kronenberg M, Sutton CL, Braun J. The Crohn's disease-associated bacterial protein 12 is a novel enteric T cell superantigen. Immunity 2001;15:149-58.
42. Elling P, Olsson AT, Elling H. Synchronious variations of the incidence of temporal arteritis and polymyalgia rheumatica in different regions of Denmark; assocation with epidemics of Mycoplasma pneumoniae infection. J Rheumatol 1996;23:112-19.
43. Uddhammar A, Boman J, Juto P, Rantapä Dahlqvist S. Antibodies against Chlamydia pneumoniae, cytomegalovirus, enteroviruses and respiratory syncytial virus in patients with polymyalgia rheumatica. Clin Exp Rheumatol 1997;15:299-302.
44. Cimmino MA, Grazi G, Baratelli E, Accardo S. Increased prevalence of antibodies to adenovirus and respiratory syncytial virus in polymyalgia rheumatica. Clin Exp Rheumatol 1993;11:309-13.
45. Duhaut P, Bosshard S, Calvet A, Pinede L, Demolombe Rague S, Dumontet C, et al. Giant cell arteritis, polymyalgia rheumatica, and viral hypothesis: a multicenter, prospective case-control study. Groupe de reserche sur lárterite a cellules geantes. J Rheumatol 1999;26:361-9.
46. Russo MG, Waxman J, Abdoh AA, Serebro LH. Correlation between infection and the onset of the giant cell (temporal) arteritis syndrome. A trigger mechanism? Arthritis Rheum 1995;38:374-80.
47. Roche NE, Fulbright JW, Wagner AD, Hunder GG, Goronzy JJ, Weyand CM. Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis. Arthritis Rheum 1993;36:1286-94.
48. Dasgupta B, Panayi GS. Interleukin-6 in serum of patients with polymyalgia rheumatica and giant cell arteritis. Br J Rheumatol 1990;29:456-8.
49. Lecron JC, Roblot P, Chevalier S, Morel F, Alderman E, Gombert J, et al. High circulating leukaemia inhibitory factor (LIF) in patients with giant cell arteritis: independent regulation of LIF and IL-6 under corticosteroid therapy. Clin Exp Immunol 1993;92:23-6.
50. Straub RH, Konecna L, Hrach S, Rothe G, Kreutz M, Schölmerich J, et al. Serum dehydroepiandrosterone (DHEA) and DHEA sulfate are negatively correlated with serum interleukin-6 (IL-6), and DHEA inhibits IL-6 secretion from mononuclear cells in man in vitro: possible link between endocrinosenescence and immunosenescence. J Clin Endocrinol Metab 1998;83:2012-17.
51. Bartolome-Pacheco MJ, Amado JA, Lopez-Hoyos M, Blanco R, Garcia-Unzueta MT, Rodriguez-Valverde V, et al. Hypothalamic-pituitary-adrenocortical axis function in patients with polymyalgia rheumatica and giant cell arteritis. Semin Arthritis Rheum 2003;32:266-72.
52. Martínez-Taboada VM, Bartolome MJ, Mata-Arnaiz C, Blanco R, López Hoyos M, Corrales A, et al. Distribution of HLA-DRB1 alleles of patients with polymyalgia rheumatica and giant cell arteritis in the Spanish population [abstract]. Arthritis Rheum 43(suppl):S123.
53. Machado EBV, Gabriel SE, Beard CM, Michet CJ, O'Fallon WM, Ballard DJ. A population -based case-control study of temporal arteritis: evidence for an association between temporal arteritis and degenerative vascular disease? Int J Epidemiol 1989;18:836-41.
54. Duhaut P, Pinede L, Demolonbe-Rague S, Loire R, Seydoux D, Ninet J, et al. Giant cell arteritis and cardiovascular risk factors. A multicenter, prospective case-control study. Arthritis Rheum 1998;41:1960-5.
55. Martinez-Taboada VM, Bartolome MJ, Fernandez-Gonzalez MD, Blanco R, Rodriguez-Valverde V, Lopez-Hoyos M. Homocysteine levels in polymyalgia rheumatica and giant cell arteritis: influence of corticosteroid therapy. Rheumatology (Oxford) 2003;42:1055-61.